Showing 1 - 10 of 34,558
Persistent link: https://www.econbiz.de/10009537998
This paper studies the effect of two regulatory instruments - a price cap and a reference price system - a mandatory substitution rule, and the combination of both on generic competition in a Salop-type model with an off-patent brand-name drug and n differentiated generic versions. The price cap...
Persistent link: https://www.econbiz.de/10010510801
This paper analyzes a maximum price system and a reference price system in a vertical differentiation model with a brand-name drug and a generic. In particular, both instruments are compared with respect to their performance in reducing public expenditure, limiting financial exposure of...
Persistent link: https://www.econbiz.de/10010224844
Persistent link: https://www.econbiz.de/10010375165
Persistent link: https://www.econbiz.de/10010364680
Persistent link: https://www.econbiz.de/10010488405
manufacturer) on pharmaceutical regulation in a North-South framework with a firm's endogenous decision to export to the South … via reimbursement limits. Parallel trade may relax regulation in the source country of parallel imports (South) and … intensify regulation in the destination country (North): In the source country, parallel trade may relax regulation both under a …
Persistent link: https://www.econbiz.de/10011986314
, inflation regulation can cause inflation to rise, but only because firms are reducing launch prices to make the regulation bind …
Persistent link: https://www.econbiz.de/10011617425
Persistent link: https://www.econbiz.de/10011820436
This paper reviews recent empirical evidence on privatisation in developing countries. Particular emphasis is placed on new areas of research such as the distributional impacts of privatisation. Overall, the literature now reflects a more cautious and nuanced evaluation of privatisation. Thus it...
Persistent link: https://www.econbiz.de/10011571943